Man nearly suffers collapsed lung during freak accident masturbating
Swiss man, 20, was left in intensive care after suffering rare lung injury from masturbating Suffered sudden chest pain and struggled to breathe while pleasuring himself Air escaped from lung and became lodged in ribcage, spreading around body First ever…
Read MorePeople with allergy disorders could be at greater risk of having high blood pressure
Dr Chris Steele shares diet tips on reducing blood pressure We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on…
Read MoreMass exodus of GPs in UK ‘may put patients at risk’
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info…
Read MoreCancer: Spending too long in a ‘reclining’ position increases your risk suggests research
Cancer symptoms: Top 14 early signs to look out for We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on…
Read MoreNew CDC analyses shine light on mental health of U.S. high school students during the pandemic
New CDC analyses, published today, shine additional light on the mental health of U.S. high school students during the COVID-19 pandemic, including a disproportionate level of threats that some students experienced. According to the new data, in 2021, more than…
Read MoreCan Early Allergen Immunotherapy Prevent Future Asthma?
Providing allergen immunotherapy (AIT) to allergy patients, especially children, before they develop asthma may protect them from developing asthma in the future, a systematic review and meta-analysis conducted in Europe suggests. Mariana Farraia “This study supports a possible preventive effect…
Read MoreSubcutaneous mAb may benefit high-risk outpatients with COVID-19
For high-risk outpatients with mild-to-moderate COVID-19, subcutaneously administered monoclonal antibody (mAb) treatment with casirivimab and imdevimab is associated with reduced risk for 28-day hospitalization or death compared with no mAb treatment, according to a study published online April 12 in…
Read More‘Impulsive psychopaths like crypto’: Research shows how ‘dark’ personality traits affect Bitcoin enthusiasm
Since the invention of Bitcoin in 2009 the global cryptocurrency market has grown from nothing to a value of around US$2 trillion. From a price of US$1 in 2011, Bitcoin rose to an all-time high of more than US$63,000 in…
Read MoreLeukemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy
Acute lymphoblastic leukemia (ALL) cells from patients whose cancers did not respond to CD19-targeted CAR T therapy had gene regulation signatures that could potentially facilitate treatment resistance, according to results presented at the AACR Annual Meeting 2022, held April 8-13….
Read MoreFDA Clears Transit Scientific’s XO Cross Catheters for Coronary Use
Transit Scientific announced US Food and Drug Administration (FDA) 510(k) clearance of its XO Cross Support Catheter platform to include coronary use. The platform is indicated to guide and support guidewire access, allow guidewire exchanges, and deliver saline or contrast…
Read More